MEKINIST pdr 4.7 mg p sol buvable fl

7680691340017 CH-69134 L01EE01 07.16.1.
MEKINIST pdr 4.7 mg p sol buvable fl
MEKINIST pdr 4.7 mg p sol buvable fl
MEKINIST pdr 4.7 mg p sol buvable fl
1 / 3
google

Details

Product number
6913401
CPT
-
Packaging group
1
Unit
Flasche(n)
Composition
trametinibum 4.7 mg ut trametinibi dimethylis sulfoxidi solvatum, sulfobutylbetadexum natricum 9400 mg, sucralosum, acidum citricum monohydricum, dinatrii phosphas, E 202 corresp. kalium 58 mg, E 218 75.2 mg, aromatica Erdbeere, pro vitro, natrium 198 mg.

Articles (1)

Mekinist 4.7 mg, Pulver zur Herstellung einer Lösung zum Einnehmen
Pulver zur Herstellung einer Lösung zum Einnehmen
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/05/2025
Patient information leaflet
Français
13/05/2025
Patient information leaflet
Italien
13/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
4.7 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
9400.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
58.0 MG Substance HBESI
(N/A)
75.2 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
198.0 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
69134
Drug name
Mekinist, Pulver zur Herstellung einer Lösung zum Einnehmen
Galenic form
PULO
ATC Code
L01EE01
Authorization status
Z
Dispensation category
A
First authorization
05/09/2023
Authorization expiration date
04/09/2028
IT number
07.16.1.
Domain
Human medicine
Field of application
Melanom, nicht-kleinzelliges Lungenkarzinom

Packaging details

Description (FR)
MEKINIST pdr 4.7 mg p sol buvable fl
Description (DE)
MEKINIST Plv 4.7 mg für Lös zum Einnehmen Fl
Market launch
05/09/2023
Narcotic (BTM)
No